We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.

Already a subscriber and want to update your preferences? Click here.

BACK TO NEWS

MEDIA MENTIONS

JUN 1 2020

Section 505(b)(2) new drug applications – untapped opportunities - IAM Magazine

Matthew Fedowitz, shareholder in the firm's Intellectual Property section, authored an article "Section 505(b)(2) new drug applications – untapped opportunities" which appeared in IAM Magazine.